Sevabertinib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Sevabertinib, covering 2026-02-10 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) [Phase 3]